OpenAlex
PricingAboutJobs
Log inGet started
Work

Front-line bevacizumab in serous epithelial ovarian cancer: biomarker analysis of the FINAVAST trial.

PubMed

Year: 2010
Type: article
Source: PubMed
Authors: Peeter Karihtala, Johanna Mäenpää, Taina Turpeenniemi-Hujanen, Ulla Puistola
Institutions: Oulu University Hospital, Tampere University Hospital, University of Oulu
Language: English

Topic: Ovarian cancer diagnosis and treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: bevacizumab, serous epithelial ovarian cancer, predictive biomarkers, vascular endothelial growth factor, 8-hydroxy-2'-deoxyguanosine, TIMP-1, hypoxia-inducible factor-1α, MMP-9, VEGF receptors, progression-free survival, combination chemotherapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2145191418
FWCI: 1.347
Cites: 22
Cited by: 17
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security